A Simple and Fast Method to Sequence the Full-Length Spike Gene for SARS-CoV-2 Variant Identification from Patient Samples
| dc.rights.license | open | en_US |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | RECORDON-PINSON, Patricia | |
| dc.contributor.author | BLONDOT, Marie-Lise | |
| dc.contributor.author | BELLECAVE, Pantxika | |
| dc.contributor.author | LAFON, Marie-Edith | |
| dc.contributor.author | TUMIOTTO, Camille | |
| dc.contributor.author | MÉTIFIOT, Mathieu | |
| dc.contributor.author | ANDREOLA, Marie-Line | |
| dc.date.accessioned | 2023-05-22T13:21:09Z | |
| dc.date.available | 2023-05-22T13:21:09Z | |
| dc.date.issued | 2021-09 | |
| dc.identifier.issn | 2673-8112 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/182226 | |
| dc.description.abstractEn | Since the beginning of the pandemic, a race has been underway to detect SARS-CoV-2 virus infection (PCR screening, serological diagnostic kits), treat patients (drug repurposing, standard care) and develop a vaccine. After almost a year of active circulation worldwide, SARS-CoV-2 variants have appeared in different countries. Those variants include mutations in multiple regions of the genome, particularly in the spike gene. Because this surface protein is a key player in both the spread of the virus and the efficacy of vaccine strategies, the challenge is to efficiently monitor the appearance of spike mutations in the population. The present work describes a procedure based on the widely available Sanger technology to produce a full-length sequence of the spike gene from patient-derived samples. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title.en | A Simple and Fast Method to Sequence the Full-Length Spike Gene for SARS-CoV-2 Variant Identification from Patient Samples | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.3390/covid1010028 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Microbiologie et Parasitologie | en_US |
| bordeaux.journal | COVID | en_US |
| bordeaux.page | 337-344 | en_US |
| bordeaux.volume | 1 | en_US |
| bordeaux.hal.laboratories | MFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234 | en_US |
| bordeaux.issue | 1 | en_US |
| bordeaux.institution | CNRS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | hal | |
| hal.identifier | hal-03364618 | |
| hal.version | 1 | |
| hal.export | false | |
| workflow.import.source | hal | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=COVID&rft.date=2021-09&rft.volume=1&rft.issue=1&rft.spage=337-344&rft.epage=337-344&rft.eissn=2673-8112&rft.issn=2673-8112&rft.au=RECORDON-PINSON,%20Patricia&BLONDOT,%20Marie-Lise&BELLECAVE,%20Pantxika&LAFON,%20Marie-Edith&TUMIOTTO,%20Camille&rft.genre=article |
